Skip to main content
Citadel Group logo

Citadel Group - Investor Relations & Filings

Listed
Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,241 across all filing types
Latest filing 2026-07-07 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Brera Holdings plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel rules for persons with interests in relevant securities representing 1% or more. It details shareholdings and specific trading activities (purchases and sales) by Citadel Group in Brera Holdings plc. While it involves share transactions, it is a regulatory disclosure of position/dealing rather than a company's own share buyback (POS) or a director's personal trade (DIRS). As it is a specific regulatory disclosure form, it falls under the RNS (Regulatory Filings) category.
2026-07-07 English
Form 8.3 - Tate & Lyle plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. This document details the position and dealings of Citadel Group in relation to Tate & Lyle PLC. While it involves shareholdings, it is specifically a regulatory disclosure related to takeover activity rather than a 'Major Shareholding Notification' (which typically refers to TR-1 filings for 3% thresholds) or a 'Director's Dealing'. Given the specific nature of Rule 8.3 disclosures and the lack of a more specific category for takeover-related position disclosures, it falls under the 'Regulatory Filings' (RNS) category.
2026-07-07 English
Form 8.3 - DCC plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel rules. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in a company (DCC plc). This type of disclosure is a specific regulatory requirement for transparency during takeover situations and does not fit into categories like financial reports, management changes, or dividends. It is a mandatory regulatory filing.
2026-07-07 English
Form 8.3 - Forward Industries Inc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel rules for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details opening positions and specific share dealings (purchases and sales) by Citadel Group in Forward Industries Inc. This type of disclosure is a regulatory requirement related to M&A activity, but it is specifically a 'Major Shareholding Notification' or 'Director's Dealing' equivalent in the context of takeover rules. Given the specific category list, 'MRQ' (Major Shareholding Notification) is the most accurate classification for a disclosure of interests crossing a percentage threshold in the context of a takeover.
2026-07-07 English
Form 8.3 - Advanced Medical Solutions Group plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details shareholdings and derivative positions (CFDs) in Advanced Medical Solutions Group plc. While it relates to M&A activity, it is a disclosure of shareholding positions rather than an M&A announcement itself. Given the specific nature of these disclosures and their regulatory purpose, they are best classified as Major Shareholding Notifications (MRQ).
2026-07-07 English
Form 8.3 - AMG Critical Materials N. V.
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details share dealings and positions. While it involves shareholdings, it is a regulatory disclosure rather than a 'Major Shareholding Notification' (which typically refers to TR-1 filings for crossing thresholds) or a 'Director's Dealing'. Given the specific nature of Form 8.3 filings under the Takeover Code, it falls under the 'Regulatory Filings' (RNS) category as a standard compliance document.
2026-07-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.